The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Clovis Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer Health; BeiGene; Clovis Oncology; Janssen-Cilag; Novartis; Pfizer
Speakers' Bureau - Janssen-Cilag; Pfizer
Research Funding - Sanofi (Inst)
Health-related quality of life (HRQoL) and patient-reported outcomes at final analysis of the TITAN study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).
 
Neeraj Agarwal
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Foundation Medicine; Foundation One Inc; Genentech; Janssen Oncology; Lilly; Lilly; Lilly; Medivation/Astellas; MEI Pharma; Merck; Nektar; Novartis; Pfizer; Pfizer; Pharmacyclics; Seagen
Research Funding - Active Biotech (Inst); Amgen (Inst); AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Simon Chowdhury
No Relationships to Disclose
 
Anders Bjartell
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; Merck; Sandoz
Speakers' Bureau - Astellas Pharma; Bayer; Janssen-Cilag
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ferring (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen-Cilag
 
Byung Ha Chung
Honoraria - Astellas Pharma; Ipsen; JW Pharmaceutical; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen; Myovant Sciences; Pfizer; Roche
 
Andrea Juliana Pereira de Santana Gomes
No Relationships to Disclose
 
Robert Given
Consulting or Advisory Role - Janssen Oncology
Speakers' Bureau - Bayer Schering Pharma; Janssen Oncology; Myovant Sciences
 
Álvaro Juárez
Honoraria - Astellas Pharma; Bayer; Bayer (Inst); Janssen Oncology; Janssen Oncology (Inst); Pfizer
Consulting or Advisory Role - Janssen Oncology
Research Funding - Bayer (Inst); Exelixis (Inst); Janssen Oncology (Inst)
 
Axel Stuart Merseburger
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen-Cilag; MSD Oncology
Speakers' Bureau - Ipsen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen-Cilag (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen; Janssen-Cilag
 
Mustafa Ozguroglu
Honoraria - Astellas Pharma; Janssen Oncology (Inst); Novartis
Consulting or Advisory Role - AstraZeneca; MSD Oncology
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Hirotsugu Uemura
Consulting or Advisory Role - Janssen; Pfizer; Sanofi
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Janssen; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo/UCB Japan (Inst); Kissei Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Takeda (Inst)
 
Dingwei Ye
No Relationships to Disclose
 
Sabine Doris Brookman-May
Employment - Janssen Research & Development
Leadership - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Suneel Mundle
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Sharon Anne McCarthy
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson and Johnson
 
Florence Lefresne
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Honoraria - Johnson & Johnson
Research Funding - Johnson & Johnson
Travel, Accommodations, Expenses - Johnson & Johnson
(OPTIONAL) Uncompensated Relationships - Johnson & Johnson
 
Shiva Dibaj
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Katherine B. Bevans
Employment - Janssen
 
Kim N. Chi
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Constellation Pharmaceuticals; Daiichi Sankyo; ESSA; Janssen; Merck; POINT Biopharma; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)